Novel immunotherapies for rheumatoid arthritis.

作者信息

Richardson Sarah, Isaacs John

机构信息

Newcastle University, UK.

出版信息

Clin Med (Lond). 2013 Aug;13(4):391-4. doi: 10.7861/clinmedicine.13-4-391.

DOI:10.7861/clinmedicine.13-4-391

PMID:23908512

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4954309/

Abstract

摘要

相似文献

Novel immunotherapies for rheumatoid arthritis.

Clin Med (Lond). 2013 Aug;13(4):391-4. doi: 10.7861/clinmedicine.13-4-391.

Emerging immunotherapies for rheumatoid arthritis.

Hum Vaccin Immunother. 2014;10(4):822-37. doi: 10.4161/hv.27910. Epub 2014 Feb 17.

Joint approach.

Minn Med. 2009 Sep;92(9):22-5.

[Immunotherapy in rheumatoid arthritis; current status].

Ned Tijdschr Geneeskd. 1996 Jun 15;140(24):1255-9.

Introduction: new treatment paradigms in rheumatoid arthritis.

Am J Orthop (Belle Mead NJ). 2007 Mar;36(3 Suppl):2-3.

Immunotherapeutic approaches of rheumatic disorders.

Acta Clin Belg. 1998 Jun;53(3):155-61.

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.

Eur Cytokine Netw. 1997 Sep;8(3):297-300.

[Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].

Rev Med Interne. 2000 Oct;21(10):854-62. doi: 10.1016/s0248-8663(00)00236-8.

New therapies for rheumatoid arthritis.

Clin Exp Immunol. 2005 May;140(2):195-204. doi: 10.1111/j.1365-2249.2005.02744.x.

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.

Arthritis Res Ther. 2009;11(5):128. doi: 10.1186/ar2809. Epub 2009 Oct 6.

引用本文的文献

Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells.

Cells. 2020 Jul 10;9(7):1660. doi: 10.3390/cells9071660.

Personalized medicine in rheumatology.

Reumatologia. 2016;54(4):177-186. doi: 10.5114/reum.2016.62472. Epub 2016 Oct 5.

Pim-2/mTORC1 Pathway Shapes Inflammatory Capacity in Rheumatoid Arthritis Synovial Cells Exposed to Lipid Peroxidations.

Biomed Res Int. 2015;2015:240210. doi: 10.1155/2015/240210. Epub 2015 May 4.

Effects of thapsigargin on the proliferation and survival of human rheumatoid arthritis synovial cells.

ScientificWorldJournal. 2014 Feb 9;2014:605416. doi: 10.1155/2014/605416. eCollection 2014.

本文引用的文献

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.

Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18.

The role of biosimilars in the treatment of rheumatic diseases.

Ann Rheum Dis. 2013 Mar;72(3):322-8. doi: 10.1136/annrheumdis-2012-202715. Epub 2012 Dec 19.

The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis.

Ann Rheum Dis. 2013 Dec;72(12):1947-55. doi: 10.1136/annrheumdis-2012-202220. Epub 2012 Dec 6.

Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis.

Ann Rheum Dis. 2013 Mar;72(3):329-36. doi: 10.1136/annrheumdis-2011-201117. Epub 2012 Jun 11.

Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Ann Rheum Dis. 2013 Feb;72(2):229-34. doi: 10.1136/annrheumdis-2011-201108. Epub 2012 Apr 24.

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.

Ann Rheum Dis. 2012 Jun;71(6):869-74. doi: 10.1136/annrheumdis-2011-200622. Epub 2012 Jan 12.

Anti-TNF therapy.

Best Pract Res Clin Rheumatol. 2011 Aug;25(4):549-67. doi: 10.1016/j.berh.2011.10.004.

Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.

Ann Rheum Dis. 2011 Oct;70(10):1810-4. doi: 10.1136/ard.2011.152769. Epub 2011 Jul 21.

Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.

Arch Neurol. 2011 Sep;68(9):1156-64. doi: 10.1001/archneurol.2011.103. Epub 2011 May 9.

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Ann Rheum Dis. 2011 Apr;70(4):583-9. doi: 10.1136/ard.2010.139774. Epub 2011 Feb 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr
超能文献

Novel immunotherapies for rheumatoid arthritis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献

Suppr超能文献

Novel immunotherapies for rheumatoid arthritis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献

Suppr
超能文献